Trial
NCT03467217
Losartan for the Treatment of Pediatric NAFLD
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators
Johns Hopkins University
Condition
NAFLD - Nonalcoholic Fatty Liver Disease
Intervention
Losartan potassium
Why stopped
Trial stopped for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-21